Dr Reddys Laboratories has received the Establishment Inspection
Report (EIR) from USFDA, for the company's formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
